[ Price : $8.95]
Nutra Pharma says it will launch OTC and Rx versions of its pain reliever Nyloxin.[ Price : $8.95]
Cubist Pharmaceuticals closes enrollment in its CB-500,929 (ecallantide) Phase 2 program, an investigational therapy for reducing ...[ Price : $8.95]
FDA approves two Tris Pharma NDAs for once-daily clonidine extended-release suspension and tablets to treat hypertension.[ Price : $8.95]
Members of FDAs Cardiovascular and Renal Drugs Advisory Committee say that Novartis Certican appears to be safe and effective in p...[ Price : $8.95]
FDA approves Octapharmas wilate for treating spontaneous and trauma-induced bleeding episodes in patients with all types of von Wi...[ Price : $8.95]
Consulting editor John Scharmann reviews the history of FDAs regional offices and asks whether they have a value-added function.[ Price : $8.95]
FDA affairs commentator Steven Gross says the agency is on the wrong course in its efforts to develop an all-encompassing single p...[ Price : $8.95]
FDA says that facilities and CT technologists should take steps to ensure that patients undergoing CT perfusion scans are not expo...